Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
By R. Seder, Lee-Jah Chang, Mary E. Enama, Kathryn L. Zephir, Uzma N. Sarwar, Ingelise J. Gordon, Lasonji Holman, E. James, P. Billingsley, A. Gunasekera and 32 more. Science, 2013
772 citations recorded by the source corpus.
Subfields: Public Health, Environmental and Occupational Health, Virology
View Paper: https://www.semanticscholar.org/paper/d99dc36d168ea935ee537682fc4109c5a498a18a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Malaria: Biology and Disease. (2016, positive): “Attenuated live cell sporozoite vaccine, (PfSPZ) have delivered sterile protection (no blood stage development) against homologous challenge (injection with sporozoites of the same parasite strain) in early Phase I/IIa clinical trials (Epstein et al., 2011; Seder et al., 2013).”
- The contribution of vaccination to global health: past, present and future (2014, background): “However, there has recently been a renewed interest in use of wholecell vaccines, which have the advantage of presenting multiple antigens, and whole-cell, attenuated pneumococcal [11] and malaria [12,13] vaccines have recently been developed and are being evaluated in clinical trials.”